[Skip to Content]
[Skip to Content Landing]
Article
August 11, 1997

Clinical and Ethical Issues in the Treatment of a Jehovah's Witness With Acute Myeloblastic Leukemia

Author Affiliations

From the Health Law and Ethics Program, University of Newcastle (Drs Kerridge and Lowe), and the Hematology Unit, Mater Hospital (Drs Kerridge, Seldon, Enno, and Deveridge), Newcastle, Australia.

Arch Intern Med. 1997;157(15):1753-1757. doi:10.1001/archinte.1997.00440360189020
Abstract

We report the first documented case of the use of peripheral blood stem cell autografting in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. This case illustrates the complex ethical and clinical issues that arise in the treatment of such patients.

Arch Intern Med. 1997;157:1753-1757

×